1 |
|
|
Conditions: |
| Cancer of Skin; Solid Tumors |
Intervention: |
| Procedure: Immunotherapy treatment for solid tumors |
|
2 |
|
|
Condition: |
| Breast Cancer |
Intervention: |
| Drug: zoledronic acid |
|
3 |
|
|
Condition: |
| Pancreatic Cancer |
Intervention: |
| Drug: curcumin (+ gemcitabine) |
|
4 |
|
|
Condition: |
| Breast Cancer |
Intervention: |
| Behavioral: gourment cooking workshop |
|
5 |
|
|
Conditions: |
| Hematological Malignancy; Neoplasm Metastasis |
Intervention: |
| Procedure: DLI sensitized against antigens expressed by the host. |
|
6 |
|
|
Condition: |
| Non Small Cell Lung Cancer |
Intervention: |
| Drug: Mistletoe extract |
|
7 |
|
|
Condition: |
| Hormone Refractory Prostate Cancer |
Intervention: |
| Drug: Fermented Wheat germ extract |
|
8 |
|
|
Condition: |
| Stomach Neoplasms |
Interventions: |
| Procedure: Chemotherapy; Procedure: surgery; Procedure: radiotherapy |
|
9 |
|
|
Conditions: |
| Multiple Myeloma; Tumors |
Intervention: |
| Biological: Peptide Vaccine (MUC-1) |
|
10 |
|
|
Condition: |
| Non-Small Cell Lung Cancer |
Intervention: |
| Drug: chemotherapy +/- disulfiram |
|
11 |
|
|
Condition: |
| Colon Neoplasm |
Interventions: |
| Drug: CELECOXIB; Drug: CURCUMIN |
|
12 |
|
|
Conditions: |
| Metastatic Cancer; Newcastle Disease Virus (NDV) |
Intervention: |
| Procedure: Newcastle Virus |
|
13 |
|
|
Condition: |
| Cancer |
Intervention: |
| Behavioral: cognitive-behavior groups |
|
14 |
|
|
Condition: |
| Pancreatic Cancer |
Interventions: |
| Drug: Gemcitabine; Drug: Curcumin; Drug: Celebrex |
|
15 |
|
|
Condition: |
| Tumors |
Intervention: |
| Procedure: Cell therapy |
|
16 |
|
|
Condition: |
| Metastatic Solid Tumors |
Intervention: |
| Biological: Tumor Cell Vaccine |
|
17 |
|
|
Conditions: |
| Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis |
Intervention: |
| Drug: Erlotinib, Temozolomide |
|
18 |
|
|
Condition: |
| Colon Cancer |
Intervention: |
| Device: LapCAC Laparoscopic Compression Anastomosis Clip |
|
19 |
|
|
Conditions: |
| Solid Tumors; Bone Metastases |
Interventions: |
| Drug: Xeloda; Procedure: External Beam Radiotherapy |
|
20 |
|
|
Condition: |
| Metastatic Solid Tumors |
Intervention: |
| Drug: Cell therapy with bispecific antibodies |
|
21 |
|
|
Condition: |
| Breast Neoplasms |
Intervention: |
| Drug: cetuximab paclitaxel |
|
22 |
|
|
Condition: |
| Chronic Myeloid Leukemia |
Intervention: |
| Biological: Allogeneic tumor cell vaccine |
|
23 |
|
|
Conditions: |
| Ulcer; Wounds and Injuries |
Intervention: |
| Drug: topical morphine |
|
24 |
|
|
Condition: |
| Adenocarcinoma Clear Cell |
Intervention: |
| Drug: Capecitabine (Xeloda) |
|
25 |
|
|
Condition: |
| Oral Mucositis |
Intervention: |
| Drug: Tocopherol |
|
26 |
|
|
Condition: |
| Metastatic Melanoma |
Intervention: |
| Procedure: Immunotherapy treatment for melanoma |
|
27 |
|
|
Condition: |
| Metastatic Melanoma |
Intervention: |
| Procedure: Procedure - Adoptive cell transfer |
|
28 |
|
|
Condition: |
| Rhabdomyosarcoma |
Intervention: |
| Drug: doxorubicin, cytoxan |
|
29 |
|
|
Condition: |
| Non-Hodgkin’s Lymphoma |
Intervention: |
| Drug: 90Yttrium Ibritumomab Tiuxetan (Zevalin) |
|
30 |
|
|
Condition: |
| Hodgkin Lymphoma |
Intervention: |
| Procedure: interim PET/CT |
|
31 |
|
|
Conditions: |
| Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Intervention: |
| Drug: Campath-1H /ATG |
|
32 |
|
|
Condition: |
| Leukemia, Myeloid, Philadelphia-Positive |
Intervention: |
| Drug: Pegylated Interferon and Imatinib |
|
33 |
|
|
Condition: |
| Non-Hodgkin's Lymphoma |
Intervention: |
| Drug: ibritumomab tiuxetan (zevalin) |
|
34 |
|
|
Conditions: |
| Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Intervention: |
| Drug: treosulfan |
|
35 |
|
|
Conditions: |
| Multiple Myeloma; Newly Diagnosed Patients |
Interventions: |
| Drug: Melphalan; Drug: Lenalidomide |
|
36 |
|
|
Conditions: |
| Myelodysplastic Syndromes; Myelofibrosis |
Intervention: |
| Device: DBM for creation of bone marrow microenvironment |
|
37 |
|
|
Condition: |
| Cystic Fibrosis |
Intervention: |
| Procedure: PET-CT |
|
38 |
|
|
Condition: |
| Myelodysplastic Syndrome |
Intervention: |
| Drug: Exjade |
|
39 |
|
|
Conditions: |
| Polycystic Ovary Syndrome; Ovarian Hyperstimulation Syndrome |
Intervention: |
| Procedure: In Vitro Maturation of immature oocytes |